Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

79.31
Delayed Data
As of Aug 26
 -0.24 / -0.30%
Today’s Change
69.90
Today|||52-Week Range
98.97
-7.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line1.8B1.0B2.0B1.8B
 
 
 
 
 
Depreciation1.4B1.0B1.3B1.5B
 
 
 
 
 
Total Other Cash Flow57.2M-336.0M299.9M93.4M
 
 
 
 
 
Funds From Operations3.3B1.7B3.6B3.4B
 
 
 
 
 
Funds From/For Other Operating Expenses110.1M-2.4B2.1B282.6M
 
 
 
 
 
Net Cash Flow - Operating Activities3.2B4.1B1.5B3.1B
 
 
 
 
 
 
InvestingIncrease In Investments-36.7M-710.7M0.000.00
 
 
 
Decrease In Investments0.00427.2M0.000.00
 
 
Capital Expenditures-587.0M-740.8M-377.3M-452.2M
 
 
 
 
 
Fixed Asset Disposal0.00236.6M518.5M97.9M
 
 
 
 
Net Assets From Acquisitions -310.0M-24.7M-405.8M-18.5M
 
 
 
 
 
Other Investing - Uses-205.6M845.7M-521.4M-484.4M
 
 
 
 
 
Other Investing - Sources340.9M-523.2M29.4M4.5M
 
 
 
 
 
Net Cash Flow Investing-798.5M-1.6B-756.6M-852.6M
 
 
 
 
 
 
FinancingShort Term Borrowings----0.00----
Long Term Borrowings-314.5M1.9B5.5B-1.5B
 
 
 
 
 
Long Term Debt Reduction0.00-3.1B0.000.00
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-1.9B-3.6B-180.3M-98.5M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-33.3M44.7M-6.3B-101.7M
 
 
 
 
 
Other Sources - Financing0.001.6B0.005.0M
 
 
 
Other Uses - Financing-6.8M-29.2M28.4M-28.4M
 
 
 
 
 
Net Cash Flow - Financing-2.2B-2.7B-1.0B-1.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-66.7M-345.8M39.2M-45.2M
 
 
 
 
 
 
Net Change In Cash138.1M-255.3M-251.9M618.3M